Data |
Ora |
Fonte |
Titolo |
02/5/2024 | 15:00 | BW | Amylyx Pharmaceuticals to Report First Quarter 2024.. |
10/4/2024 | 15:00 | BW | Amylyx Pharmaceuticals Announces Interim Data From Ongoing.. |
09/4/2024 | 11:45 | PRNUS | The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc... |
08/4/2024 | 15:00 | BW | Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss.. |
05/4/2024 | 11:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
04/4/2024 | 13:00 | BW | Amylyx Pharmaceuticals Announces Formal Intention to Remove.. |
02/4/2024 | 11:45 | PRNUS | The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc... |
29/3/2024 | 10:45 | PRNUS | The Gross Law Firm Announces the Filing of a Securities.. |
26/3/2024 | 10:45 | PRNUS | Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact.. |
25/3/2024 | 13:00 | PRNUS | INVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX).. |
22/3/2024 | 10:45 | PRNUS | The Gross Law Firm Notifies Shareholders of Amylyx.. |
19/3/2024 | 10:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
14/3/2024 | 14:00 | BW | Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,.. |
14/3/2024 | 10:50 | PRNUS | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff.. |
11/3/2024 | 13:44 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
11/3/2024 | 10:50 | PRNUS | Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law.. |
08/3/2024 | 13:10 | EDGAR2 | Form 8-K - Current report |
08/3/2024 | 13:00 | BW | Amylyx Pharmaceuticals Announces Topline Results From Global.. |
07/3/2024 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
07/3/2024 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
07/3/2024 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
07/3/2024 | 11:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
29/2/2024 | 00:22 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
29/2/2024 | 00:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
29/2/2024 | 00:13 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
27/2/2024 | 23:59 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
26/2/2024 | 11:45 | PRNUS | AMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx.. |
23/2/2024 | 22:05 | BW | Amylyx Pharmaceuticals Announces Inducement Grants Under.. |
22/2/2024 | 22:29 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
22/2/2024 | 14:22 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
22/2/2024 | 13:08 | EDGAR2 | Form 8-K - Current report |
22/2/2024 | 13:00 | BW | Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year.. |
22/2/2024 | 11:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law.. |
15/2/2024 | 22:05 | BW | Amylyx Pharmaceuticals to Report Fourth Quarter and Full.. |
15/2/2024 | 15:00 | BW | Amylyx Pharmaceuticals to Present Updates on its AMX0114 and.. |
15/2/2024 | 11:00 | PRNUS | Lost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class.. |
08/2/2024 | 15:00 | BW | Amylyx Pharmaceuticals Announces Completion of Enrollment in.. |
11/1/2024 | 23:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
11/1/2024 | 23:10 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 22:07 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
22/12/2023 | 15:00 | BW | Amylyx Pharmaceuticals Announces First Participant Dosed in.. |
19/12/2023 | 22:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
07/12/2023 | 13:00 | EDGAR2 | Form 8-K - Current report |
04/12/2023 | 15:00 | BW | Amylyx Pharmaceuticals Announces Publication of Data Showing.. |
29/11/2023 | 23:15 | BW | Amylyx Pharmaceuticals Announces Inducement Grants Under.. |
28/11/2023 | 13:00 | BW | Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as.. |
27/11/2023 | 15:00 | BW | RELYVRIO® and AMX0114 Data to be Presented at 34th.. |
21/11/2023 | 15:00 | BW | Amylyx Pharmaceuticals to Participate at the 6th Annual.. |
21/11/2023 | 02:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
09/11/2023 | 13:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |